
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.95 | 3.31 | 2.36 |
Shares | 99.08 | 99.08 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 9.66 | 11.59 |
Price to Book | 1.20 | 1.39 |
Price to Sales | 1.08 | 0.98 |
Price to Cash Flow | 7.02 | 6.33 |
Dividend Yield | 4.59 | 4.01 |
5 Years Earnings Growth | 11.46 | 9.78 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 35.61 | 22.27 |
Technology | 15.28 | 8.44 |
Industrials | 14.78 | 14.73 |
Healthcare | 7.78 | 10.62 |
Energy | 6.25 | 6.65 |
Communication Services | 5.95 | 6.10 |
Consumer Cyclical | 5.51 | 10.75 |
Basic Materials | 4.79 | 7.25 |
Utilities | 1.93 | 3.44 |
Consumer Defensive | 1.36 | 9.47 |
Real Estate | 0.77 | 1.87 |
Number of long holdings: 357
Number of short holdings: 9
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Taiwan Semicon | TW0002330008 | 3.68 | 864.00 | -1.03% | |
ABB | CH0012221716 | 2.05 | 43.25 | +2.22% | |
Deutsche Telekom AG | DE0005557508 | 2.04 | 31.180 | -4.79% | |
Allianz | DE0008404005 | 1.70 | 359.10 | +0.73% | |
Kinross Gold | CA4969024047 | 1.64 | 14.490 | -1.23% | |
ING Groep | NL0011821202 | 1.56 | 16.88 | +1.38% | |
Novartis ADR | US66987V1098 | 1.50 | 112.14 | +0.87% | |
Bank Ireland | IE00BD1RP616 | 1.48 | 10.44 | -1.32% | |
BNP Paribas | FR0000131104 | 1.47 | 72.81 | +0.80% | |
Bank of China H | CNE1000001Z5 | 1.46 | 4.340 | +0.23% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dunham Small Cap Value Fund Class N | 87.71M | 7.96 | 3.09 | 6.95 | ||
Dunham Small Cap Value Fund Class A | 6.96M | 15.71 | 7.29 | 7.74 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review